T1	p 67 145	prophylaxis of postoperative nausea and vomiting after breast cancer surgery :
T2	p 218 237	Japanese patients .
T3	p 290 322	patient under general anesthesia
T4	p 449 457	patients
T5	p 881 925	breast cancer surgery in Japanese patients .
T6	p 1011 1025	Japanese women
T7	p 1689 1822	A total of 100 women ( mean [ SD ] age , 52 [ 7 ] years ; height , 154 [ 6 ] cm ; weight , 54 [ 7 ] kg ) were included in the study .
T8	i 20 62	propofol , droperidol , and metoclopramide
T9	i 190 208	placebo-controlled
T10	i 556 564	propofol
T11	i 624 631	placebo
T12	i 774 782	propofol
T13	i 792 846	conventional antiemetics droperidol and metoclopramide
T14	i 984 1002	placebo-controlled
T15	i 1091 1099	propofol
T16	i 1112 1122	droperidol
T17	i 1138 1152	metoclopramide
T18	i 1168 1195	placebo ( isotonic saline )
T19	i 2070 2078	propofol
T20	i 2105 2115	droperidol
T21	i 2146 2160	metoclopramide
T22	i 2188 2195	placebo
T23	i 2296 2304	propofol
T24	i 2325 2335	droperidol
T25	i 2342 2350	propofol
T26	i 2355 2365	droperidol
T27	i 2441 2455	metoclopramide
T28	i 2643 2651	propofol
T29	i 2666 2676	droperidol
T30	i 2860 2868	propofol
T31	i 2873 2883	droperidol
T32	i 2898 2912	metoclopramide
T33	i 2927 2936	placebo .
T34	o 82 115	postoperative nausea and vomiting
T35	o 379 421	postoperative nausea and vomiting ( PONV )
T36	o 521 527	PONV .
T37	o 646 650	PONV
T38	o 740 748	efficacy
T39	o 870 874	PONV
T40	o 1339 1343	PONV
T41	o 1549 1574	extrapyramidal symptoms .
T42	o 2019 2023	PONV
T43	o 2254 2258	PONV
T44	o 2422 2426	PONV
T45	o 2501 2524	Extrapyramidal symptoms
T46	o 2597 2601	PONV
T47	o 2825 2829	PONV